Cargando…

Cost-effectiveness of using amyloid positron emission tomography in individuals with mild cognitive impairment

BACKGROUND: Amyloid positron emission tomography (PET) makes it possible to diagnose Alzheimer’s disease (AD) in its prodromal phase including mild cognitive impairment (MCI). This study evaluated the cost-effectiveness of including amyloid-PET for assessing individuals with MCI. METHODS: The target...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Young-Sil, Youn, HyunChul, Jeong, Hyun-Ghang, Lee, Tae-Jin, Han, Ji Won, Park, Joon Hyuk, Kim, Ki Woong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364075/ https://www.ncbi.nlm.nih.gov/pubmed/34391439 http://dx.doi.org/10.1186/s12962-021-00300-9

Ejemplares similares

Cerebrospinal Fluid Levels of β-Amyloid 40 and β-Amyloid 42 are Proportionately Decreased in Amyloid Positron-Emission Tomography Negative Idiopathic Normal-Pressure Hydrocephalus Patients
por: Kim, Hyun Jae, et al.
Publicado: (2019)

Comparison of neurodegenerative types using different brain MRI analysis metrics in older adults with normal cognition, mild cognitive impairment, and Alzheimer’s dementia
por: Choi, Myungwon, et al.
Publicado: (2019)

Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Management of Cervical Dystonia
por: Lee, Han Byul, et al.
Publicado: (2012)

Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography
por: Therriault, Joseph, et al.
Publicado: (2022)

Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography
por: Risacher, Shannon L., et al.
Publicado: (2017)

Statistical Parametric Mapping in Amyloid Positron Emission Tomography
por: Smith, Natasha M., et al.
Publicado: (2022)

A Single Baseline Amyloid Positron Emission Tomography Could Be Sufficient for Predicting Alzheimer’s Disease Conversion in Mild Cognitive Impairment
por: Choo, IL Han, et al.
Publicado: (2022)

Computed Tomography Radiomics for Residual Positron Emission Tomography-Computed Tomography Uptake in Lymph Nodes after Treatment
por: Kim, Chu Hyun, et al.
Publicado: (2020)

(18)F-FDG Positron-Emission Tomography/Computed Tomography Findings of Radiographic Lesions Suggesting Old Healed Tuberculosis
por: Jeong, Yun-Jeong, et al.
Publicado: (2014)

Amyloid deposition in semantic dementia: a positron emission tomography study
por: Brown, Eric E., et al.
Publicado: (2016)

Semiquantitative Approach to Amyloid Positron Emission Tomography Interpretation in Clinical Practice
por: Franceschi, Ana M., et al.
Publicado: (2022)

Diagnosis of an indistinct Leydig cell tumor by positron emission tomography-computed tomography
por: Kong, Jinkyoung, et al.
Publicado: (2019)

Radiochemistry for positron emission tomography
por: Rong, Jian, et al.
Publicado: (2023)

Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update
por: Farid, Karim, et al.
Publicado: (2017)

Evaluation of factors associated with medication adherence in patients with bipolar disorder using a medication event monitoring system: a 6‐month follow‐up prospective study
por: Youn, HyunChul, et al.
Publicado: (2022)

Positron emission tomography
Publicado: (1995)

Positron Emission Tomography
por: Piepmeier, Joseph M.
Publicado: (1986)

Positron emission tomography
por: Paans, A M J
Publicado: (2006)

Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms
por: Lyoo, Chul Hyoung, et al.
Publicado: (2018)

Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations
por: Witte, Michael M., et al.
Publicado: (2015)

Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer’s Disease and Other Tauopathies
por: Maschio, Cinzia, et al.
Publicado: (2022)

Pulmonary actinomycosis mimicking lung cancer on positron emission tomography
por: Choi, Hayoung, et al.
Publicado: (2017)

Regional Amyloid Deposition in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Evaluated by [(18)F]AV-45 Positron Emission Tomography in Chinese Population
por: Huang, Kuo-Lun, et al.
Publicado: (2013)

Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment
por: Hu, Yan, et al.
Publicado: (2022)

Decreased Cortical Thickness and Local Gyrification in Individuals with Subjective Cognitive Impairment
por: Youn, HyunChul, et al.
Publicado: (2021)

Characterization of focal hypermetabolic thyroid incidentaloma: An analysis with F-18 fluorodeoxyglucose positron emission tomography/computed tomography parameters
por: Lee, Haejun, et al.
Publicado: (2022)

Positron Emission Tomography/Computed Tomography in the Staging of Colon Cancer
por: Lee, Jae Hyung, et al.
Publicado: (2014)

Is There Any Role of Positron Emission Tomography Computed Tomography for Predicting Resectability of Gallbladder Cancer?
por: Kim, Jaihwan, et al.
Publicado: (2014)

Positron emission tomography imaging of amyloid-beta plaque deposition: a decade of translation
por: Price, Julie C, et al.
Publicado: (2012)

Lacrimal gland uptake on F-18 florbetapir amyloid positron emission tomography scan
por: Itani, Malak, et al.
Publicado: (2017)

Longitudinal pathways of cerebrospinal fluid and positron emission tomography biomarkers of amyloid-β positivity
por: Sala, Arianna, et al.
Publicado: (2020)

Effect of apolipoprotein E phenotype on the association of plasma amyloid β and amyloid positron emission tomography imaging in Japan
por: Tateno, Amane, et al.
Publicado: (2017)

Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity
por: Chun, Min Young, et al.
Publicado: (2023)

Positron emission tomography: An overview
por: Shukla, A. K., et al.
Publicado: (2006)

Scintillators for positron emission tomography
por: Moses, W W, et al.
Publicado: (1995)

Detectors in positron emission tomography
por: Zatcepin, Artem, et al.
Publicado: (2022)

Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease
por: Lin, Szu-Ying, et al.
Publicado: (2019)

The role of (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography in the differential diagnosis of pericardial disease
por: Hyeon, Cheol Won, et al.
Publicado: (2020)

Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer
por: Oldan, Jorge Daniel, et al.
Publicado: (2018)

Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging
por: Ossenkoppele, Rik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ru2o7fgoj2gbhnruloi3j044r4